Largest ever protein study set to revolutionise cancer and dementia tests - Tens of millions of pounds in investment is being ...
The world’s largest study of proteins circulating the human body will begin in the UK this month, with the aim of pinpointing ...
The average life expectancy of people diagnosed with dementia ranges from nine years at age 60 to 4.5 years at age 85 for ...
The average life expectancy of people diagnosed with dementia ranges from 9 years at age 60 to 4.5 years at age 85 for women ...
Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...
A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer ...
Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...
A study from the Keck School of Medicine of USC has tested a biomarker linked to vascular dementia across four separate ...
Summary: A new study has identified a biomarker, DTI-ALPS, which connects glymphatic system dysfunction to vascular dementia.
Groundbreaking research reveals how a cancer drug could restore brain function in early Alzheimer's patients by targeting glucose metabolism. Here's what you need to know.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback